Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 2, 1999, Pages 378-384

  Romanowski, Eric G ^a   Bartels, Stephen P ^b   Gordon, Y Jerold ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BAUSCH AND LOMB   (United States)

^c University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CIDOFOVIR; TRIFLURIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL INFECTION; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RABBIT; SLIT LAMP; TOPICAL DRUG ADMINISTRATION; VIRUS LOAD;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ANIMALS; ANTIVIRAL AGENTS; CORNEA; CYTOSINE; FEMALE; HERPESVIRUS 1, HUMAN; KERATITIS, DENDRITIC; OPHTHALMIC SOLUTIONS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; RABBITS; RANDOM ALLOCATION; TRIFLURIDINE; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 0032951322     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Pepose JS, Leib DA, Stuart PM, Easty DL. Herpes simplex virus diseases: anterior segment of the eye. In: Pepose JS, Holland GN, Willhelmus KR, eds. Ocular Infection and Immunity. St. Louis, MO: Mosby; 1996:905-932.
2. Pavan-Langston D. Clinical disease herpetic infections. In: Smolin G, Thoft RA, eds. The Cornea. 3rd ed. Boston: Little, Brown & Co; 1994:183-215.
3. De Clercq E. Therapeutic potential of HPMPC as an antiviral drug. Rev Med Virol. 1993;3:85-96.
4. Naesens L, Snoeck R, Andrei G, et al. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infection. Antiviral Chem Chemother. 1997;8:1-23.
5. Gordon YJ, Romanowski EG, Araullo-Cruz T. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Invest Ophthalmol Vis Sci. 1994;35:4135-4143.
6. Gordon YJ, Romanowski E, Araullo-Crux T, De Clercq E. Pretreatment with topical 0.1% (s)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular replication model. Cornea. 1992;11:529-533.
7. Maudgal PC, De Clercq E. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis. Invest Ophthalmol Vis Sci. 1991;32:1816-1820.
8. Gordon YJ, Romanowski EG, Araullo-Cruz T. HPMPC, a broad-spectrum topical antiviral, inhibits HSV-1 replication and promotes healing of dendritic keratitis in the NZ rabbit ocular model. Cornea. 1994;13:516-520.
9. Kaufman HE, Varnell ED, Thompson HW. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Arch Ophthalmol. 1998;116:777-780.
10. Holy A, Rosenberg I. Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compounds. Coll Czech Chem Commun. 1987;52:2801-2909.
11. De Clercq E, Sakuma T, Baba M, et al. Antiviral activity of phosphonylmethoxyalkyl derivatives of purines and pyrimidines. Antiviral Res. 1987;8:261-272.
12. Gordon YJ, Armstrong JA, Brown SI, Becker Y. Herpesvirus type 1 thymidine kinase. Am J Ophthalmol. 1983;95:175-181.
13. Snoeck R, Andrei G, Gerard M, et. al. Successful treatment of progressive mucocutaneous infection due to acyclovir and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clin Infect Dis. 1994;18:570-578.
14. Lalezari JP, Drew WL, Glutzer E, et al. Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS. J Infect Dis. 1994;170:570-572.
15. La Lau C. Oosterhuis JA, Versteeg J, et al. Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial. Br J Ophthalmol. 1982;66:506-508.
16. Hovding G. A comparison between acyclovir and trifluorothymidine ophthalmic ointment in the treatment of epithelial dendritic keratitis: a double blind, randomized parallel group trial. Acta Ophthalmol. 1989;67:51-54.
17. Romanowski EG, Gordon YJ. The effect of topical NSAIDS on the antiviral activity of topical cidofovir in the Ad5/NZ rabbit ocular model [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4): S148. Abstract nr 691.